Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines

Purpose. Liposomal systems may be useful as a cytokine supplementin tumor cell vaccines by providing a cytokine reservoir at the antigenpresentation site. Here, we examined the effect of liposomeincorporation of mIFNγ on its potency as adjuvant in an established tumor cellvaccination protocol in the murine B16 melanoma model. Adjuvanticityof the mIFNγ-liposomes was compared to that achieved bymIFNγ-gene transfection of the B16 tumor cells. Furthermore, we studiedwhether liposomal incorporation of mIFNγ indeed increases theresidence time of the cytokine at the vaccination site.